Showing results (151-160 of 319) with videos related to
Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2007
Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group BEverett E Vokes, James E Herndon, Michael J Kelley, et al.Journal of Carcinogenesis|December 10, 2013
O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancerRifat Hasina, Mosmi Surati, Ichiro Kawada, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2010
Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633Stephen L Graziano, Lin Gu, Xiaofei Wang, et al.Archives of Otolaryngology--Head & Neck Surgery|December 22, 2010
Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancerKent W Mouw, Daniel J Haraf, Kerstin M Stenson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancerTanguy Y Seiwert, Daniel J Haraf, Ezra E W Cohen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non-small-cell lung cancerAlex A Adjei, Ann Mauer, Laura Bruzek, et al.Clinical Lung Cancer|October 8, 2009
Cooperative group research endeavors in small-cell lung cancer: current and future directionsRandeep Sangha, Primo N Lara, Alex A Adjei, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2020
Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 AssayHans Juergen Grote, Zheng Feng, Michael Schlichting, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignanciesChristopher W Ryan, Nicholas J Vogelzang, Everett E Vokes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904Jeffrey A Bogart, Lydia Hodgson, Stephen L Seagren, et al.Pageof 32